Akèy › Maladi Alzheimer › Indiana › Indianapolis
Etid klinik pou Maladi Alzheimer nan Indianapolis, IN
14 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Dominantly Inherited Alzheimer Network (DIAN)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Indiana University-Indiana Alzheimer Disease Center, Indianapolis
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Ap rekrite
- Eskenazi Health, Indianapolis
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Ap rekriteFaz 4
- Josephson Wallack Munshower Neurology P.C., Indianapolis
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
- Indiana University Health Neuroscience Center, Indianapolis
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Ap rekriteFaz 3
- Josephson Wallack Munshower Neurology, PC, Indianapolis
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Ap rekriteFaz 1
- Clinical Trial Site, Indianapolis
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Indiana University School of Medicine, Indianapolis
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Ap rekriteFaz 2/3Volontè an sante akeyi
- Indiana University School of Medicine, Indianapolis
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Ap rekriteFaz 3
- Care Access - South Indianapolis, Indianapolis
- Josephson Wallack Munshower Neurology, PC, Indianapolis
Trial-Ready Cohort-Down Syndrome (TRC-DS)
Ap rekriteEtid obsèvasyon
- Indiana University, Indianapolis
Late Onset Alzheimer's Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- NCRAD at Indiana University, Indianapolis
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Ap rekrite
- Indiana University, Indianapolis
Nicotinic Acid for the Treatment of Alzheimer's Disease
Ap rekriteFaz 1/2
- IU Health Neuroscience Center, Indianapolis
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
Ap rekrite
- IU Health, Indianapolis
- Community Health Network, Indianapolis
Etid Maladi Alzheimer nan lòt vil
- Boston, MA26 etid
- Orlando, FL25 etid
- St. Louis, MO22 etid
- New York City, NY21 etid
- Miami, FL20 etid
- Tampa, FL17 etid
- Atlanta, GA16 etid
- Philadelphia, PA15 etid
- The Villages, FL15 etid
- Phoenix, AZ15 etid
- Los Angeles, CA14 etid
- West Palm Beach, FL13 etid
Lòt etid nan Indianapolis
- Kansè Poumon ki pa ti selil32 etid
- Kansè (tout kalite)24 etid
- Ensifizyans kadyak23 etid
- Obèsite20 etid
- Kansè nan tete20 etid
- Kansè Metastatik19 etid
- Kansè kolorektal18 etid
- Kansè ovè17 etid
- Maladi kadyovaskilè17 etid
- Kansè poumon16 etid
- Dyabèt tip 114 etid
- Kansè Endomèt14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.